About: Sofituzumab vedotin

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Sofituzumab vedotin (INN; development code DMUC5754A) is a monoclonal antibody designed for the treatment of ovarian cancer. This drug was developed by Genentech/Roche.

Property Value
dbo:abstract
  • Sofituzumab vedotin (INN; development code DMUC5754A) is a monoclonal antibody designed for the treatment of ovarian cancer. This drug was developed by Genentech/Roche. (en)
dbo:casNumber
  • 1418200-58-4
dbo:fdaUniiCode
  • 2X3CKG601L
dbo:kegg
  • D11241
dbo:wikiPageID
  • 46644107 (xsd:integer)
dbo:wikiPageLength
  • 1818 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1084075200 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • none (en)
dbp:casNumber
  • 1418200 (xsd:integer)
dbp:chemspiderid
  • none (en)
dbp:kegg
  • D11241 (en)
dbp:molecularWeight
  • 144.700000 (xsd:double)
dbp:source
  • zu/o (en)
dbp:synonyms
  • DMUC5754A (en)
dbp:target
  • carbohydrate antigen 125 (en)
dbp:type
  • mab (en)
dbp:unii
  • 2 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Sofituzumab vedotin (INN; development code DMUC5754A) is a monoclonal antibody designed for the treatment of ovarian cancer. This drug was developed by Genentech/Roche. (en)
rdfs:label
  • Sofituzumab vedotin (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License